GLP1R and neurodegenerative disease: Interestingly, reduced activity of GLP-1R in the CNS results in microglia activation and reactive astrogliosis (Park et al., 2021), suggesting that activation of GLP-1R by GLP-1R agonist could be a viable strategy to attenuate activation of microglia and astrogliosis in neurodegenerative diseases.